108 results
Page 3 of 6
S-3
zthihw x8x1lvwh
4 Nov 22
Shelf registration
4:47pm
8-K
EX-99.1
5rxszz
3 Nov 22
Annexon Reports Third Quarter 2022 Financial Results and Plans to Provide Updates on Complement Therapeutic Portfolio in January 2023
6:45am
8-K
EX-99.1
pi9 2o4kss9cay
8 Aug 22
Annexon Biosciences Highlights Business and Portfolio Progress and Key Anticipated Milestones and Reports Second Quarter 2022 Financial Results
4:30pm
8-K
EX-10.1
9gsdii huv7jljk9c
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-99.1
bhtu0iyuc0mkotq
7 Jun 22
Other Events
4:06pm
8-K
EX-99.1
mch3fzeir esr11
9 May 22
Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and Reports First Quarter 2022 Financial Results
4:20pm
POS AM
f6j0n3k
1 Mar 22
Prospectus update (post-effective amendment)
6:38pm
POSASR
hwyb3ye20
1 Mar 22
Automatic shelf registration (post-effective amendment)
4:01pm
8-K
EX-99.1
ebit02
4 Jan 22
ANX005 Has Been Generally Well-Tolerated and Has Shown Full Target Engagement of C1q in the CSF
4:16pm
8-K
EX-99.1
p5ft76yn74110cjbrrva
9 Nov 21
Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results
4:16pm